[ad_1]
Health
Reuters
Mike Segar
The US Food and Drug Administration (FDA) has approved a new drug for the treatment of adults with acute myeloid leukemia who have a specific genetic mutation.
According to the FDA, the new drug, Tibsovo, is the first treatment for leukemia, or leukemia, which prevents progression of the disease and limits its spread through the interaction of drug substances with certain molecules that contribute to growth and The spread of cancer
The effectiveness and safety of the new drug were determined after 174 adult patients had the disease.
The trials showed that 37% of 110 patients periodically needed blood transfusions or platelets, the new one is not needed for at least 56 days.
Read more
In addition,
The United States Food and Drug Administration (FDA) is an agency of the United States Department of Health and Human Rights, in charge of protection and promotion of public health through the US Department of Health Regulation and supervision of food safety and medicine medicine
Source: Anatolia
[ad_2]
Source link
